{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:50:37Z","timestamp":1776271837141,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T00:00:00Z","timestamp":1261094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s11255-009-9688-9","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T08:32:30Z","timestamp":1261038750000},"page":"1055-1062","source":"Crossref","is-referenced-by-count":17,"title":["Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3\u20134"],"prefix":"10.1007","volume":"42","author":[{"given":"Ashima","family":"Gulati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijesh","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tathagata","family":"Bose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Hari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,18]]},"reference":[{"issue":"Suppl 3","key":"9688_CR1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ndt\/11.supp3.130","volume":"11","author":"E Slatopolsky","year":"1996","unstructured":"Slatopolsky E, Delmez JA (1996) Pathogenesis of secondary hyperparathyroidism. Nephrol Dial Transplant 11(Suppl 3):130\u2013135","journal-title":"Nephrol Dial Transplant"},{"key":"9688_CR2","first-page":"S1","volume":"42","author":"National Kidney Foundation (NKF)","year":"2003","unstructured":"National Kidney Foundation (NKF) (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1\u2013S201","journal-title":"Am J Kidney Dis"},{"key":"9688_CR3","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","volume":"72","author":"WN Suki","year":"2007","unstructured":"Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garett L et al (2007) Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 72:1130\u20131137","journal-title":"Kidney Int"},{"key":"9688_CR4","first-page":"539","volume":"4","author":"AG Clark","year":"1989","unstructured":"Clark AG, Oner A, Ward G, Turner C, Rigden S, Haycock GB et al (1989) Safety and efficacy of calcium carbonate in children with chronic renal failure. Nephrol Dial Transplant 4:539\u2013544","journal-title":"Nephrol Dial Transplant"},{"key":"9688_CR5","first-page":"68","volume":"6","author":"JW Coburn","year":"1986","unstructured":"Coburn JW, Norris KC, Nebeker HG (1986) Osteomalacia and bone disease arising from aluminum. Semin Nephrol 6:68\u201389","journal-title":"Semin Nephrol"},{"key":"9688_CR6","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1093\/ndt\/15.11.1892","volume":"15","author":"F Eifinger","year":"2000","unstructured":"Eifinger F, Wahn F, Querfeld U, Pollock M, Gevargez A, Kriener P et al (2000) Coronary artery calcifications in children and young adults treated with renal replacement therapy. Nephrol Dial Transplant 15:1892\u20131894","journal-title":"Nephrol Dial Transplant"},{"key":"9688_CR7","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s11255-007-9276-9","volume":"39","author":"GB Spasovski","year":"2007","unstructured":"Spasovski GB (2007) Bone health and vascular calcification relationships in chronic kidney disease. Int Urol Nephrol 39:1209\u20131216","journal-title":"Int Urol Nephrol"},{"key":"9688_CR8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s11255-008-9477-x","volume":"40","author":"DJ Goldsmith","year":"2008","unstructured":"Goldsmith DJ, Covic A (2008) Calcium and the saga of the binders: accumulating controversy, or building consensus? Int Urol Nephrol 40:1009\u201310014","journal-title":"Int Urol Nephrol"},{"key":"9688_CR9","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/ndt\/12.8.1640","volume":"12","author":"SL Burke","year":"1997","unstructured":"Burke SL, Slatopolsky EA, Goldberg DI (1997) Renagel, a novel calcium and aluminum free phosphate binder, inhibits phosphate absorption in normal volunteers. Nephrol Dial Transplant 12:1640\u20131644","journal-title":"Nephrol Dial Transplant"},{"key":"9688_CR10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","volume":"29","author":"GM Chertow","year":"1997","unstructured":"Chertow GM, Burke SK, Lazarus JM, Stenzel K, Wombolt D, Goldberg D et al (1997) Poly (allylamine hydrochloride) (Rena Gel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis 29:66\u201371","journal-title":"Am J Kidney Dis"},{"key":"9688_CR11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1523-1755.1999.00240.x","volume":"55","author":"EA Slatopolsky","year":"1999","unstructured":"Slatopolsky EA, Burke SK, Dillon MA, The Renagel Study Group (1999) RenaGel, a nonabsorbed calcium and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. Kidney Int 55:299\u2013307","journal-title":"Kidney Int"},{"key":"9688_CR12","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00467-003-1298-7","volume":"18","author":"H Mahdavi","year":"2003","unstructured":"Mahdavi H, Kuizon BD, Gales B, Wang HJ, Elashoff RM, Salusky IB (2003) Sevelamer hydrochloride: an effective phosphate binder in dialyzed children. Pediatr Nephrol 18:1260\u20131264","journal-title":"Pediatr Nephrol"},{"key":"9688_CR13","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, stratification. Am J Kidney Dis 39:S1\u2013S266","journal-title":"Am J Kidney Dis"},{"key":"9688_CR14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1525-139X.2007.00204.x","volume":"20","author":"RichardA Sherman","year":"2007","unstructured":"Sherman RichardA (2007) Dietary phosphate restriction and protein intake in dialysis patients. A misdirected focus. Semin in Dialysis 20:16\u201318","journal-title":"Semin in Dialysis"},{"key":"9688_CR15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/clinchem\/12.12.871","volume":"12","author":"H Goldenberg","year":"1996","unstructured":"Goldenberg H, Fernandez A (1996) Simplified method for the estimation of inorganic phosphorus in body fluids. Clin Chem 12:871\u2013882","journal-title":"Clin Chem"},{"key":"9688_CR16","volume-title":"Textbook of Clinical Chemistry","author":"CA Burtis","year":"1998","unstructured":"Burtis CA, Ashwood ER (1998) Textbook of Clinical Chemistry, 3rd edn. Philadelphia, WB Saunders pp1917","edition":"3"},{"key":"9688_CR17","first-page":"159","volume":"12","author":"DB Cottrell","year":"1979","unstructured":"Cottrell DB, Frings CS (1979) Evaluation of the Beckman creatinine analyzer 2. Clin Biol Chem 12:159\u2013161","journal-title":"Clin Biol Chem"},{"key":"9688_CR18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1210\/jcem-57-5-1007","volume":"57","author":"AW Lindall","year":"1999","unstructured":"Lindall AW, Elting J, Ells J, Roos BA (1999) Estimation of biologically active intact parathyroid hormone in normal and hyperparathyroid sera by sequential N-terminal immunoextraction and midregion radioimmunoassay. J Clin Endocrinol Metab 57:1007\u20131014","journal-title":"J Clin Endocrinol Metab"},{"key":"9688_CR19","first-page":"70","volume":"61","author":"K Schaefer","year":"1991","unstructured":"Schaefer K, Scheer J, Asmus G, Umlauf E, Hagemann J, von Herrath D (1991) The treatment of uraemic hyperphosphatemia with calcium acetate and calcium carbonate: a comparative study. Nephrol Dial Transplant 61:70\u201375","journal-title":"Nephrol Dial Transplant"},{"key":"9688_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1440-1797.1995.tb00008.x","volume":"1","author":"J Connolly","year":"1995","unstructured":"Connolly J, Harris DC (1995) Calcium acetate versus calcium carbonate in chronic hemodialysis. Nephrology 1:47\u201350","journal-title":"Nephrology"},{"key":"9688_CR21","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/ndt\/13.9.2303","volume":"13","author":"DI Goldberg","year":"1998","unstructured":"Goldberg DI, Dillon MA, Slatopolsky EA, Garrett B, Gray JR, Marbury T, Weinberg M, Wombolt D, Burke SK (1998) Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients. Nephrol Dial Transplant 13:2303\u20132310","journal-title":"Nephrol Dial Transplant"},{"key":"9688_CR22","first-page":"18","volume":"51","author":"GM Chertow","year":"1999","unstructured":"Chertow GM, Dillon M, Burke SK, Steg M, Bleyer AJ, Garrett BN, Domoto DT, Wikes BM, Wombolt DG, Slatopolsky EA (1999) A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients. Clin Nephrol 51:18\u201326","journal-title":"Clin Nephrol"},{"key":"9688_CR23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/j.ajkd.2005.12.039","volume":"47","author":"AK Pieper","year":"2006","unstructured":"Pieper AK, Haffner D, Hoppe B, Dittrich K, Offner G, Bonzel KE, John U, Fr\u00fcnd S, Klaus G, St\u00fcbinger A, D\u00fcker G, Querfeld U (2006) A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis 47:625\u2013635","journal-title":"Am J Kidney Dis"},{"key":"9688_CR24","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1523-1755.2004.00590.x","volume":"65","author":"WY Qunibi","year":"2004","unstructured":"Qunibi WY, Hootkins RE, McDowell LL, Meyer MS, Simon M, Garza R et al (2004) Treatment of hyperphosphatemia in hemodialysis patients: the Calcium Acetate Renagel Evaluation (CARE study). Kidney Int 65:1914\u20131926","journal-title":"Kidney Int"},{"key":"9688_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.ki.5002059","volume":"71","author":"GA Block","year":"2007","unstructured":"Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM (2007) Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71:1\u20134","journal-title":"Kidney Int"},{"key":"9688_CR26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-149-38853","volume":"149","author":"SB Arnaud","year":"1975","unstructured":"Arnaud SB, Goldsmith RS, Lambert PW, Go VL (1975) 25-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man. Exp Biol Med 149:570\u2013572","journal-title":"Exp Biol Med"},{"key":"9688_CR27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000063307","volume":"92","author":"MP Paz Marco","year":"2002","unstructured":"Paz Marco MP, Muray S, Betriu A, Craver L, Belart M, Fernandez E (2002) Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients. Nephron 92:499\u2013500","journal-title":"Nephron"},{"key":"9688_CR28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1592\/phco.29.5.554","volume":"29","author":"AB Pai","year":"2009","unstructured":"Pai AB, Shepler BM (2009) Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications. Pharmacotherapy 29:554\u2013561","journal-title":"Pharmacotherapy"},{"key":"9688_CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/ajkd.2001.26850","volume":"38","author":"MJ Landray","year":"2001","unstructured":"Landray MJ, Thambyrajah J, Mc Glynn FJ (2001) Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 38:537\u2013546","journal-title":"Am J Kidney Dis"},{"key":"9688_CR30","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/ndt\/gfm421","volume":"22","author":"M Tonelli","year":"2007","unstructured":"Tonelli M, Wiebe N, Culleton B, Lee H, Klarenbach S, Shrive F et al (2007) Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients. Nephrol Dial Transplant 22:2856\u20132866 (for the Alberta Kidney Disease Network)","journal-title":"Nephrol Dial Transplant"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9688-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-009-9688-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9688-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T08:52:47Z","timestamp":1590310367000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-009-9688-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,18]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9688"],"URL":"https:\/\/doi.org\/10.1007\/s11255-009-9688-9","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,18]]}}}